Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells

Anti-Cancer Drug Design

Volumn 13, Issue 3, 1998, Pages 207-220

  Skov, Kirsten A ^a   Adomat, Hans ^a   Farrell, Nicholas P ^b   Matthews, Jeffrey B ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bis platinum; Cross links; Hypoxia; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PLATINUM COMPLEX;

ANIMAL CELL; ARTICLE; CELL LINE; CHO CELL; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DNA BINDING; FEMALE; HYPOXIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL HYPOXIA; CHO CELLS; CRICETINAE; DNA; DNA REPAIR; ORGANOPLATINUM COMPOUNDS;

ANIMALIA;

EID: 0031979715     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ADAMS, G.E , BRECCIA, A., FIELDEN, E M & WARDMAN, p. (1990). Selective Activation of Drugs by Redox Processes. Plenum Press: New York.
2. ADAMS, G E , CLARKE, E.D , FLOCKHART, I.R., JACOBS, R.S., SEHMI, D.S., STRATFORD, I J., WARDMAN, P. & WATTS, M E. (1979a). Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. International Journal of Radiation Biology, 35, 133.
3. ADAMS, G.E., CLARKE, E.D., GRAY, P., JACOBS, R.S., STRATFORD, I J., WARDMAN, P. & WATTS, M E. (1979b) . Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. International Journal of Radiation Biology, 35, 151.
4. BILLINGS, P.C., DAVIS, R J., ENGELSBERG, B.N., SKOV, K A & HUGHES E.N. (1992). Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochemical and Biophysical Reseatch Communications, 188, 1286.
5. BOOTSMA, D. (1993). The genetic defect in DNA repair deficiency syndromes. European Journal of Cancer, 29A, 182.
6. BRIZEL, D M , SCULLY, S.P, HARRELSON, J.M., LAYFIELD, L.J., DODGE, R K., CHARLES, H C., SAMULSKI, T.V., PROSNITZ, L R & DEWHIRST, M W. (1996). Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Research, 56, 5347.
7. BUSH, R.S., JENKIN, R.D.T., ALLT, W.E.C., BEALE, F.A , BEAN, H.A., DEMBO, A.J & PRINGLE, J.F. (1978). Definitive evidence for hypoxic cells influencing cure in cancer therapy. British Journal of Cancer, 37(Suppl. III), S255.
8. 2. International Journal of Radiation Oncology, Biology and Physics, 12, 1059.
9. CHIBBER, L., STRATFORD, I.J , O'NEIL, P., SHELDON, P.W., AHMED, I & LEE, B. (1985). The interaction between radiation and complexes of cis-Pt (II) and Rh (II): studies at the molecular and cellular level. International Journal of Radiation Biology, 48, 413.
10. DABHOLKAR, M., BOSTIK-BRUTON, F., WEBER, C., BOHR, V.A & REED E. (1992). ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. Journal of the National Cancer Institute, 84, 1512.
11. FARRELL, N. (1993). Non-classical platinum antitumour complexes. Perspectives for design and development of new drugs complementary to cisplatin. Cancer Investigation, 11, 578.
12. FARRELL, N. (1994) DNA binding and chemistry of dinuclear platinum complexes. (Review.) Comments on Inorganic Chemistry, 16, 373.
13. FARRELL, N.P., DE ALMEIDA, S.G. & SKOV, K.A (1988). Bis(platinum) complexes containing two platinum cis-diammine units. Journal of the American Chemical Society, 110, 5018.
14. FARRELL, N., QU, Y, FENG, L. & VAN HOUTEN, B. (1990a). Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry, 29, 9522.
15. FARRELL, N., QU, Y & HACKER, M.P. (1990b). Cytotoxicity and antitumour activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes. Journal of Medicinal Chemistry, 33, 2179.
16. FARRELL, N., APPLETON, T.Q., QU,Y., ROBERTS,J.D., SOARES FONTES, A.P., SKOV., K., WU, P. & ZOU, Y. (1995). Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry, 34, 15480.
17. FILIPSKI, J., KOHN, K.W., PRATHER, R., & BONNER, W.M. (1979). Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiamminoplatinum (II). Science, 204, 181.
18. GATELY, D P. & HOWELL, S.B. (1993). Cellular accumulation of the anticancer agent cisplatin: a review. British Journal of Cancer, 67, 1171.
19. GRAEBER, T.G., OSMANIAN, C., JACKS, T., HOUSMAN, D.E., KOCH, C.J., LOWE, SW. & GIACCIA, A.J. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88.
20. HÖCKEL, M., SCHLENGER, K., ARAL, B., MITZE, M., SCHAFFER, U. & VAUPEL, P. (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509.
21. JOHNSON, A., QU, Y., VAN HOUTEN, B & FARRELL, N (1992). B → Z DNA conformational changes induced by a family of bis(platinum) complexes. Nucleic Acids Research, 20, 1697.
22. KNOX, R.J , FRIEDLOS, F., LYDALL, D A & ROBERTS. J J (1986). Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Research, 46, 1972.
23. KORBELIK, M. & SKOV, K.A. (1989). Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research, 119, 145.
24. KRAKER, A.J., HOESCHELE, J.D., ELLIOT, W.L., SHOWALTER, H.D.H., SERCEL, A.D. & FARRELL, N. (1992). Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups. Journal of Medicinal Chemistry, 35, 4526.
25. LOS, G. & MUGGIA, F M. (1994). Platinum resistance. New Drug Therapy, 8, 411.
26. MATTHEWS, J (1992). The Effect of Hypoxia on Cytotoxicity Uptake and DNA Binding of Cisplatin and Novel Bis (platinum) Complexes in CHO Cells. MSc Thesis: University of British Columbia.
27. MATTHEWS, J.B , ADOMAT, H. & SKOV, K A (1993). The effect of hypoxia on cytotoxicity, accumulation and DNA binding of cisplatin in Chinese hamster cells. Anti-Cancer Drugs, 4, 463.
28. MATTHEWS J , ADOMAT, H., FARRELL, N., KING, P., KOCH, C., LORD, E , PALCIC, B., POULFN, N , SANGULIN, J. & SKOV, K. (1996) Immunocytochemical labelling of aerobic and hypoxic mammalian using a platinated derivative of EF5. British Journal of Cancer, 73(Suppl. XXVII), 5200.
29. MULCAHY, R.T., GIPP, J.J., SCHMIDT, J.P. JOSWIG, C & HORCH, R.F. (1994). Nitrobenzyl phosphorodiamidates as potential hypoxia selective alkylating agents. Journal of Medicinal Chemistry, 37, 1610.
30. OLEINICK, N.L., CHIU, S, FRIEDMAN, L.R., XUE, L. & RAMAKRISHNA, N. (1986). DNA-protein cross-links: new insights into their formation and repair in irradiated mammalian cells. In Mechanism of DNA Damage and Repair. Simic, M.G., Grossman, L. & Upton, A.C. (eds). Plenum Press: New York, p. 181.
31. ROBERTS, J.D., VAN HOUTEN, B., QU, Y. & FARRELL, N.P. (1989). Interaction of novel bis(platinum) complexes with DNA. Nucleic Acids Research, 17, 9719.
32. ROSENBERG, B., VAN CAMP, L.L., TROSKO, J.E. & MANSOUR, V.H. (1969). Platinum compounds: a new class of potent anticancer agents. Nature, 222, 385.
33. SARKAR, A., HO, J.-T., MARTON, L.J. & DEEN, D.F. (1990). Effect of hypoxia on 1,3-bis(2-chloroethyl)-1-nitrosouea cytotoxicity in 9L cells. Cancer Research, 50, 2719.
34. SKOV, K.A. (1990). Toxicity of metal complexes with radiosensitizing properties. In NATO Advanced Research Seminar Series A198. Selective Activation of Drugs by Redox Processes. Adams, G.E., Breccia, A., Wardman, P. & Fielden, E.M. (eds), p. 263. Plenum: New York.
35. SKOV, K.A, (1992). The interaction of platinum complexes with low doses of X-rays in hypoxic cells: possible role of cross-links. In Low Dose Irradiation and Biological Defense Mechanisms. Sugahara, T., Sagan, L.A. & Aoyama, T. (eds), International Congress Series, No. 1013, p. 367. Elsevier: Amsterdam.
36. 3) (sensitizer)]. Radiation Research, 112, 273.
37. 3)L] in hypoxia; L = misonidazole, metronidazole. Anti-Cancer Drug Design, 5, 121.
38. 3) (quinoline)]. Anti-Cancer Drug Design, 9, 103.
39. TANNOCK, I. (1982). Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation. Cancer Research, 42, 4921.
40. THOMPSON, L.H., BUSCH, D.V., BROOKMAN, K., MOONEY, C.L. & GLASER, D.A (1981). Genetic diversity of UV-sensitive DNA repair mutants of Chinese hamster ovary cells. Proceedings of the National Academy of Sciences, USA, 78, 3734.
41. THOMPSON, L H., BROOKMAN, K.W., DILLEHAY, L.E., MOONEY C L & CARRANO, A.V (1982). Hypersensitivity to mutation and sister-chromatid-exchange induction in CHO cell mutants defective in incising DNA containing UV lesions. Somatic Cell Genetics, 8, 759.
42. VAN HOUTEN, B , ILLENYE, S., QU, Y. & FARRELL, N. (1993). Homodinuclear (platinum,platinum) and heterodinuclear (Ru,Pt) metal complexes as DNA-protein cross-linking agents: potential suicide DNA lesions. Biochemistry, 32, 11794.
43. WALTER, P., KORBELIK, M., SPADINGER, I. & SKOV, K.A. (1993). Investigation into mechanisms of the interaction between platinum complexes and irradiation at low (∼2 Gy) doses in hypoxic cells. I. The role of single-strand breaks. Radiation Oncology Investigations, 1, 137.
44. WORKMAN, R (1992). Keynote address: bioreductive mechanisms. International Journal of Radiation Oncology, Biology, Physics, 22, 631.
45. WORKMAN, P & STRATFORD, I.J. (1993). The experimental development of bioreductive drugs and their role in cancer therapy. Cancer and Metastasis Reviews, 12, 73.
46. ZOU, Y., VAN HOUTEN, B. & FARRELL, N. (1994). Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes. Biochemistry, 33, 5404.
47. ZWELLING, L J , FILIPSKI, J. & KOHN, K.W. (1979). Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum (II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)- methylamine. Cancer Research, 39, 4989.